What's new

2017.7.27
The 15th New Pharmaceutical Technology and
Engineering Conference was successfully completed.
Next conference will be held
in Kyoto on 18 and 19, July 2018.

Information held in the post

  • past Confernce
The 16th New Pharmaceutical Technology and Engineering Conference 2018
"Kyoto Internatioal Conference Center (ICC Kyoto, Japan)
Organized by: New Pharmaceutical Technology and Engineering Institute (NPTE)"
Wed. July 18, 2018
- 09:50

10:00
Opening Remarks
1 10:00

11:00
Isao Teshirogi

President and CEO, Shionogi & Co., Ltd.
『Management Practices for Sustained Increase of Corporate Value』
2 11:00

11:45
Kazunori Kataoka

Director General, Kawasaki Institute of Industrial Promotion, Innovation Center of NanoMedicine
『Self-Assembled Supramolecular Nanosystems for Smart Diagnosis and Target Therapy of Intractable Diseasese』
- 11:45

12:45
Lunch Time (60mins)
3 12:45

13:30
Eun Young Yang

Senior Director, Head of CDO Business Development Team, Contract, Compliance & Communication Center, Samsung BioLogics
『Samsung BioLogics : New Challenge by Samsung in Biopharmaceutical Industry』
4 13:30

14:15
Atsushi Maeda

Research Fellow, Drug Delivery, Pharmaceutical Research and Technology Labs.
Pharmaceutical Tecnology, Astellas Pharma, Inc.
『Design of orally disintegrating tablets employing phase transition of water-insoluble polymer by high-pressure carbon dioxide gas』
- 14:15

14:40
Coffee Break(25mins)
- 14:40

15:00
The New Pharmaceutical Technology and Engineering Foundation
Particle Design &Research Abroad Grant Awards Ceremony
5 15:00

15:45

PD Award 2018 Commemorative Lecture

Hitoshi Sasaki

Professor and Director, Department of Hospital Pharmacy, Nagasaki University Hospital
『Design of self-assembly nano-particles of nucleic acid medicine with anionic surface for cellular targeting and organ targeting』
6 15:45

16:30
Jae D. Yoo

Senior Scientific Investigator, Advanced Manufacturing Technologies, R&D Platform Technology & Science, GlaxoSmithKline
『Pharmaceutical Applications of Three Dimensional Printing (3DP) and Additive Manufacturing』
7 16:30

17:15
Shingo Sakurai

Associate Director of PMDA, Office of Manufacturing/Quality and Compliance
Pharmaceutical Medical Device Agency (PMDA)
『Draft Revision of Ministerial Ordinance of GMP』
- 17:30

19:30
Networking Party

Thur. July 19, 2018
1 9:30

10:15

Remote Presentation

Arwa El Hagrasy

Quality Assessment Lead(Acting), Office of Process and Facilities, OPQ/FDA
『Process Development and Control Strategy Implementation for Continuous Pharmaceutical Manufacturing』
2 10:15

11:00
Osamu Hiruta

Manager, Senior QA Advisor, Quality assurance Department, Reliability & Quality assurance Division, Meiji Seika Pharma Co., Ltd.
『A recent topics about the data integrity: What should we do as a pharmaceutical company?』
3 11:00

11:45
Thomas Wozniewski

Global Manufacturing & Supply Officer, Takeda Pharmaceuticals International AG
『Transforming into a new Takeda - driving profitable growth backed by Takeda`s values and culture 』
- 11:45

12:45
Lunch Time(60mins)
4 12:45

13:30
Tadashi Tsunoda

IMP Management, Pharmaceutical R&D, CMC & Production HQs
ONO PHARMACEUTICAL CO., LTD.
『ONO’s Efforts toward Continuous Manufacturing for Solid Dosage Form』
5 13:30

14:15
Hiroaki Kikuoka

Pharmaceutical Development Department Formulation I Group
Sawai Pharmaceutical Co., Ltd.
『Development of ESUEEWAN® Combination OD tablet (Film Coating OD Tablet) produced by Sawai』
- 14:15

14:45
Coffee Break (30mins)
6 14:45

15:30
Ahmad Almaya

Director, Small Molecule Design and Development; Lilly Research Labs
Eli Lilly and Company
『Lilly: The First to Design and Implement a Network of Continuous Oral Solid Dose (OSD) Manufacturing Facilities』
7 15:30

16:15
Masatoshi Karashima

Associate Director, Analytical Development, Takeda Pharmaceutical Company
『Latest trend of crystal engineering-based pharmaceutics research』
- 16:15

16:20
Closing Remarks

*Program may be subject to change